Trials / Active Not Recruiting
Active Not RecruitingNCT05135052
Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.
Efficacy of Personalised Irradiation With Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer: A Phase IV, Multi-Centre, International, Open-Label, Single Arm Study.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- Sponsor
- OncoBeta Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy of Personalised Irradiation with Rhenium-Skin Cancer Therapy (SCT) for the treatment of non-melanoma skin cancer; a phase IV multi-centre, international, open label, single arm study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rhenium-SCT | Rhenium-SCT irradiation device |
Timeline
- Start date
- 2022-01-17
- Primary completion
- 2026-07-15
- Completion
- 2027-05-15
- First posted
- 2021-11-26
- Last updated
- 2025-05-14
Locations
7 sites across 5 countries: Australia, Austria, Germany, South Africa, United Kingdom
Source: ClinicalTrials.gov record NCT05135052. Inclusion in this directory is not an endorsement.